Literature DB >> 22810818

Genomic medicine and neurology.

Jeffery M Vance, Demet Tekin.   

Abstract

The application of genetics to the understanding of neurology has been highly successful over the past several decades. During the past 10 years, tools were developed to begin genetic investigations into more common disorders such as Alzheimer disease, multiple sclerosis, autism, and Parkinson disease. The era of genomic medicine now has begun and will have an increasing effect on the daily care of common neurologic diseases. Thus it is important for neurologists to have a basic understanding of genomic medicine and how it differs from the traditional clinical genetics of the past. This article provides some basic information about genomic medicine and pharmacogenetics in neurology to help neurologists to begin to adopt these principles into their practice.

Entities:  

Year:  2011        PMID: 22810818     DOI: 10.1212/01.CON.0000396960.90316.8e

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  2 in total

1.  The documentation of consent and disclosure of neurogenetic testing outside clinical genetics.

Authors:  C Lo; J Martindale; M Hadjivassiliou; P Martin; A Dalton; O Bandmann
Journal:  Neurogenetics       Date:  2014-02-11       Impact factor: 2.660

2.  Advising patients about obtaining genomic profiles.

Authors:  Donna T Chen; Lois L Shepherd
Journal:  Neurol Clin Pract       Date:  2011-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.